A Study to Evaluate ACT-132577 in Healthy Male Subjects

NCT03100591 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: 14C-radiolabeled ACT-132577

Sponsor

Idorsia Pharmaceuticals Ltd.